Discontinuation risk comparison among ‘real-world’ newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban

• Gregory Y. H. Lip ,

  Contributed equally to this work with: Gregory Y. H. Lip, Xianying Pan, Shital Kamble, Hugh Kawabata, Jack Mardekian, Cristina Masseria, Hemant Phatak

  Roles Conceptualization, Writing – original draft, Writing – review & editing

  * E-mail: g.y.h.lip@bham.ac.uk

  Affiliations University of Birmingham Institute of Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom, Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark

  ⨯
• Xianying Pan ,

  Contributed equally to this work with: Gregory Y. H. Lip, Xianying Pan, Shital Kamble, Hugh Kawabata, Jack Mardekian, Cristina Masseria, Hemant Phatak

  Roles Formal analysis, Methodology, Writing – review & editing

  Affiliation Center for Observational Research and Data Science, Bristol-Myers Squibb Company (BMS), Princeton, New Jersey, United States of America

  ⨯
• Shital Kamble ,

  Contributed equally to this work with: Gregory Y. H. Lip, Xianying Pan, Shital Kamble, Hugh Kawabata, Jack Mardekian, Cristina Masseria, Hemant Phatak

  Roles Conceptualization, Methodology, Writing – original draft, Writing – review & editing

  Affiliation Worldwide Health Economics and Outcomes Research, Bristol-Myers Squibb Company (BMS), Princeton, New Jersey, United States of America

  ⨯
• Hugh Kawabata ,

  Contributed equally to this work with: Gregory Y. H. Lip, Xianying Pan, Shital Kamble, Hugh Kawabata, Jack Mardekian, Cristina Masseria, Hemant Phatak

  Roles Formal analysis, Methodology, Writing – review & editing

  Affiliation Center for Observational Research and Data Science, Bristol-Myers Squibb Company (BMS), Princeton, New Jersey, United States of America

  ⨯
• Jack Mardekian ,

  Contributed equally to this work with: Gregory Y. H. Lip, Xianying Pan, Shital Kamble, Hugh Kawabata, Jack Mardekian, Cristina Masseria, Hemant Phatak

  Roles Conceptualization, Methodology, Writing – review & editing

  Affiliation Outcomes & Evidence, Patient & Health Impact, Pfizer Inc., New York, New York, United States of America

  ⨯
• Cristina Masseria ,

  Contributed equally to this work with: Gregory Y. H. Lip, Xianying Pan, Shital Kamble, Hugh Kawabata, Jack Mardekian, Cristina Masseria, Hemant Phatak

  Roles Conceptualization, Writing – review & editing

  Affiliation Outcomes & Evidence, Patient & Health Impact, Pfizer Inc., New York, New York, United States of America

  ⨯
• Hemant Phatak

  Contributed equally to this work with: Gregory Y. H. Lip, Xianying Pan, Shital Kamble, Hugh Kawabata, Jack Mardekian, Cristina Masseria, Hemant Phatak

  Roles Conceptualization, Writing – original draft, Writing – review & editing

  Affiliation Worldwide Health Economics and Outcomes Research, Bristol-Myers Squibb Company (BMS), Princeton, New Jersey, United States of America

  ⨯